Overall, morin suppresses NSCLC metastasis by inhibiting ECM degradation via decreased MMP-2 and MMP-9 secretion, the downregulation of u-PA, u-PAR, and MT1-MMP expression, and the inhibition of mesenchymal marker expression. The gene discussed is PLAUR; the disease is non-small cell lung carcinoma.